- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.10. | Alps Group Inc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.10. | Alps Group Inc - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.08. | Alps Group Inc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.08. | Alps Group Inc GAAP EPS of -$0.02, revenue of $4.9M | 3 | Seeking Alpha | ||
| ALPS GROUP Aktie jetzt für 0€ handeln | |||||
| 07.08. | Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update | 1.897 | GlobeNewswire (Europe) | Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global... ► Artikel lesen | |
| 06.08. | Alps Group Inc - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 24.06. | Why Did Alps Group (ALPS) Stock Jump Over 15% After Hours? | 2 | Benzinga.com | ||
| 23.06. | Alps Group Inc - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.06. | Alps Group enters precision oncology via PDO research pact | 1 | Investing.com | ||
| 23.06. | Alps Group steigt mit Forschungspakt in die Präzisionsonkologie ein | 1 | Investing.com Deutsch | ||
| 23.06. | Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia | 1 | GlobeNewswire (USA) | ||
| 09.06. | Alps Group Inc - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 09.06. | Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022 | 2 | GlobeNewswire (USA) | ||
| 19.05. | Alps Group receives Nasdaq notice over minimum bid price deficiency | 2 | Seeking Alpha | ||
| 19.05. | Alps Group Inc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.05. | Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 263 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology... ► Artikel lesen | |
| 30.01. | Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy | 285 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology... ► Artikel lesen | |
| 31.10.25 | Alps Group Inc: Alps Announces Closing of Business Combination with Globalink Investment Inc. | 746 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | ||
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,930 | -1,30 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Alignment Healthcare Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 43,130 | +0,56 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,650 | +1,38 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| GERRESHEIMER | 33,080 | +3,70 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness | ||
| KESTRA MEDICAL TECHNOLOGIES | 30,580 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen |
ALPS GROUP INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,325 Euro und damit -0,03 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPS GROUP INC finden Sie auf Wallstreet Online.